Campbell & CO Investment Adviser LLC Adma Biologics, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 44,887 shares of ADMA stock, worth $827,267. This represents 0.06% of its overall portfolio holdings.
Number of Shares
44,887
Previous 58,810
23.67%
Holding current value
$827,267
Previous $1.18 Million
34.55%
% of portfolio
0.06%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$344 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$335 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$274 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$208 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.62B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...